This is a news story, published by CBS News, that relates primarily to Donanemab news.
For more Donanemab news, you can click here:
more Donanemab newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from CBS News, you can click here:
more news from CBS NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
donanemab targets amyloid plaques. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest intravenous donanemab infusions news, donanemab recipients news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
donanemab infusionsCBS News
•91% Informative
Donanemab is part of a class of anti-amyloid monoclonal antibodies aimed at slowing the brain's decline in early stages of Alzheimer's disease.
The FDA approved the drug on Tuesday , clearing the way for the third new Alzheimer's treatment.
The only other drug that works in a similar way on the market is lecanemab.
At least five deaths were reported in donanemab recipients in patients with these kinds of abnormalities, mostly from hemorrhages in the brain.
The most common symptoms included chills, nausea, shortness of breath, headache and chest pain.
Eli Lilly says their trials tested the drug in harder to treat patients than others studied around the same time.
VR Score
92
Informative language
92
Neutral language
74
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
17
Source diversity
8
Affiliate links
no affiliate links